Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer
Gynecologic Oncology, 07/01/09
Havrilesky LJ et al. - Surgically assessed stage IIIA endometrial adenocarcinoma recurs in approximately 20–25% of cases. A subset of stage IIIA1 with very low risk factors may be appropriate candidates for observation.
Related Articles
Endometrial Cancer
American Family Physician, 11/12/09
Relevance Score: 70%
Coffee link to reduced cancer risk
Internet Source, 11/04/09
Relevance Score: 70%
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09
Relevance Score: 69%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 69%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Presentation and Outcome of Pediatric Ovarian Germ Cell Tumor: A Study of 40 Patients
Journal of Pediatric Hematology/Oncology, 03/22/10
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer
Cancer Chemotherapy and Pharmacology, 03/22/10
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells
Laboratory Investigation, 03/22/10
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


